Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases.

BMC Cancer · 2023 · PMC10621201 · PMID 37919708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

An initial upregulation was evident at a drug concentration of 3.3 and 10 μM but failed to reach statistical significance in the treated groups at concentration of 6.6 and 20 μM.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.